Work

Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2011.11.096

Authors: Joost N. Vermeulen, Joep M.A. Lange, Stephen K. Tyring, Patrick H. Peters, Margaret Nunez, Gregory Poland, Myron J. Levin, Carrie Freeman, Ira Chalikonda, Jianjun Li, Jeffrey G. Smith, Michael J. Caulfield, Jon E. Stek, Ivan S.F. Chan, Rupert Vessey, Florian P. Schödel, Paula W. Annunziato, Katia Schlienger, Jeffrey L. Silber

Institutions: Amsterdam UMC Location University of Amsterdam, University of Amsterdam, The University of Texas Health Science Center at Houston, Mayo Clinic, University of Colorado Denver

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Merck Sharp and Dohme

OpenAlex ID: W1975297254

FWCI: 4.321

Cites: 26

Cited by: 59

Related to: 10